Safety and efficacy of zilucoplan in patients with generalised myasthenia gravis (RAISE): a randomised, double-blind, placebo-controlled, phase 3 study - Howard, JF, Jr; Bresch, S; Genge, A (Lancet Neurol, 2023)
et al.